Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Blood component replacement
- Molecular classification
- Other
01
Overview
“Blood component replacement” refers to the medical practice of transfusing individual components of blood—such as red blood cells, platelets, plasma, or cryoprecipitate—rather than whole blood, to treat deficiencies or losses due to disease, surgery, injury, or medical conditions. This approach allows clinicians to specifically address an individual patient’s hematological need, improving treatment efficiency and reducing risk. Blood components are obtained from donors and are matched to the recipient for safety[1][4][5][8]. This clinical intervention is not a molecular entity, target, nor a receptor, but rather a procedure involving various biological substances. As such, it should not be listed as a molecular or pharmacological target.
- Other names
- blood component transfusionblood product replacementblood transfusionblood component therapy
02
Biological functions
Oxygen transport (by red blood cells)Hemostasis and clot formation (by platelets and coagulation factors)Immune response (by white blood cells and plasma proteins)Volume expansion (by plasma)
03
Disease associations
AnemiaCoagulopathies/bleeding disordersImmunodeficienciesAcute blood loss (trauma, surgery)Bone marrow failureCancerOther
04
Safety considerations
Transfusion reactions (allergic, hemolytic)Transmission of infectious agentsVolume overloadTransfusion-related acute lung injury (TRALI)Iron overloadAlloimmunization
Beyond the preview
Go deeper on Blood component replacement.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Blood component replacement.